The effect of estrogen dose on postmenopausal bone loss

Area of Science:

• Endocrinology
• Bone Biology
• Pharmacology

Background:

• Postmenopausal osteoporosis is a significant health concern.
• Estrogen therapy is a known intervention for mitigating bone loss.
• The dose-response relationship of estrogen therapy on bone density requires clarification.

Purpose of the Study:

• To determine if the bone-protective effects of estrogen therapy are dose-related.
• To investigate the impact of varying ethinyl estradiol doses on bone changes in postmenopausal women.

Main Methods:

• Radiographic morphometry was used to measure sequential changes in metacarpal cortical diameters.
• 120 healthy postmenopausal women received ethinyl estradiol doses ranging from 5 to 50 micrograms daily.
• Bone loss, maintenance, and gain were assessed based on dose levels.

Main Results:

• Doses below 15 mcg/day resulted in net bone loss, primarily due to medullary cavity expansion.
• Doses between 15-25 mcg/day showed no net change in bone, with balanced resorption and apposition.
• Doses of 25 mcg/day and above led to net bone gain, as endosteal resorption was inhibited while periosteal apposition continued.

Conclusions:

• Estrogen therapy's efficacy in reducing postmenopausal cortical bone loss is significantly dose-dependent.
• Optimal therapeutic benefits for bone health with ethinyl estradiol are observed at doses of 25 mcg/day and higher.
• Understanding dose-response is crucial for effective estrogen therapy in managing postmenopausal bone loss.